References
- Tasoula E, Gregoriou S, Chalikias J, et al. The impact of acne vulgaris on quality of life and psychic health in young adolescents in Greece: results of a population survey. Ann Bras Dermatol 2012;87:862–9
- Collins JS, Beller JP, Burt Solorzano C, et al. Blunted day-night changes in luteinizing hormone pulse frequency in girls with obesity: the potential role of hyperandrogenemia. J Clin Endocrinol Metab 2014;99:2887–96
- McCartney CR, Blank SK, Prendergast KA, et al. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. J Clin Endocrinol Metab 2007;92:430–6
- Chen WC, Zouboulis CC. Hormones and the pilosebaceous unit. Dermatoendocrinology 2009;1:81–6
- Ebede TL, Arch EL, Berson D. Hormonal treatment of acne in women. J Clin Aesthet Dermatol 2009;2:16–22
- Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2012;7:CD004425
- Lam C, Zaenglein AL. Contraceptive use in acne. Clin Dermatol 2014;32:502–15
- Lucky AW, Henderson TA, Olson WH, et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol 1997;37:746–54
- Olson WH, Lippman JS, Robisch DM. The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris. Int J Fertil Womens Med 1998;43:286–90
- Redmond GP, Olson WH, Lippman JS, et al. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol 1997;89:615–22
- Paris F, Rabeolina F, Balaguer P, et al. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line. Gynecol Endocrinol 2007;23:193–7
- Hammond GL, Abrams LS, Creasy GW, et al. Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception 2003;67:93–9
- Terouanne B, Paris F, Servant N, et al. Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen–dependent cell line. Mol Cell Endocrinol 2002;198:143–7
- Molina-Molina JM, Hillenweck A, Jouanin I, et al. Steroid receptor profiling of vinclozolin and its primary metabolites. Toxicol Appl Pharmacol 2006;216:44–54
- Devineni D, Skee D, Vaccaro N, et al. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive. J Clin Pharmacol 2007;47:497–509
- Kuhl H. Comparative pharmacology of newer progestogens. Drugs 1996;51:188–215
- Zouboulis CC, Chen WC, Thornton MJ, et al. Sexual hormones in human skin. Horm Metab Res 2007;39:85–95